Retatrutide 25mg

Retatrutide supplied strictly for laboratory and scientific research purposes. This product is intended for in‑vitro and analytical research only. Not for human or veterinary use. Not a drug, supplement, or food product. All materials are provided as laboratory research chemicals and are not intended for consumption, injection, or medical use.

Retatrutide is a triple-agonist drug that targets GLP-1, GIP, and glucagon receptors to enhance insulin release, suppress appetite, and boost metabolism. In Phase 2 trials, it produced remarkable weight loss (up to 24.2% in 48 weeks) and improved metabolic and liver health. It’s given once weekly by subcutaneous injection with gradual dose escalation (up to 12 mg) and is still under clinical investigation, not yet FDA-approved.

هذا المنتج مخصص للاستخدام البحثي والمخبري فقط، وغير مخصص للاستخدام البشري أو الحيواني.

⚠️ Important NoticeThis product is intended strictly for laboratory research use
 only.
Not for human use, medical, or veterinary purposes.
No clinical or dosage advice will be provided.